Identification of SH2B2beta As an Inhibitor for SH2B1- and SH2B2alpha-promoted Janus Kinase-2 Activation and Insulin Signaling

Overview

Journal Endocrinology

Publisher Oxford University Press

Specialty Endocrinology

Date 2007 Jan 6

PMID 17204555

Citations 25

Authors

Minghua Li

Zhiqin Li

David L Morris

Liangyou Rui

Affiliations

Soon will be listed here.

Abstract

The SH2B family has three members (SH2B1, SH2B2, and SH2B3) that contain conserved dimerization (DD), pleckstrin homology, and SH2 domains. The DD domain mediates the formation of homo- and heterodimers between members of the SH2B family. The SH2 domain of SH2B1 (previously named SH2-B) or SH2B2 (previously named APS) binds to phosphorylated tyrosines in a variety of tyrosine kinases, including Janus kinase-2 (JAK2) and the insulin receptor, thereby promoting the activation of JAK2 or the insulin receptor, respectively. JAK2 binds to various members of the cytokine receptor family, including receptors for GH and leptin, to mediate cytokine responses. In mice, SH2B1 regulates energy and glucose homeostasis by enhancing leptin and insulin sensitivity. In this work, we identify SH2B2beta as a new isoform of SH2B2 (designated as SH2B2alpha) derived from the SH2B2 gene by alternative mRNA splicing. SH2B2beta has a DD and pleckstrin homology domain but lacks a SH2 domain. SH2B2beta bound to both SH2B1 and SH2B2alpha, as demonstrated by both the interaction of glutathione S-transferase-SH2B2beta fusion protein with SH2B1 or SH2B2alpha in vitro and coimmunoprecipitation of SH2B2beta with SH2B1 or SH2B2alpha in intact cells. SH2B2beta markedly attenuated the ability of SH2B1 to promote JAK2 activation and subsequent tyrosine phosphorylation of insulin receptor substrate-1 by JAK2. SH2B2beta also significantly inhibited SH2B1- or SH2B2alpha-promoted insulin signaling, including insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1. These data suggest that SH2B2beta is an endogenous inhibitor of SH2B1 and/or SH2B2alpha, negatively regulating insulin signaling and/or JAK2-mediated cellular responses.

Citing Articles

Adaptor molecules mediate negative regulation of macrophage inflammatory pathways: a closer look.

Baig M, Barmpoutsi S, Bharti S, Weigert A, Hirani N, Atre R Front Immunol. 2024; 15:1355012.

PMID: 38482001 PMC: 10933033. DOI: 10.3389/fimmu.2024.1355012.

Role of the Beta and Gamma Isoforms of the Adapter Protein SH2B1 in Regulating Energy Balance.

Argetsinger L, Flores A, Svezhova N, Ellis M, Reynolds C, Cote J Endocrinology. 2023; 164(5).

PMID: 36799031 PMC: 10282918. DOI: 10.1210/endocr/bqad032.

Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease.

Jiang L, Su H, Wu X, Shen H, Kim M, Li Y Nat Commun. 2020; 11(1):1517.

PMID: 32251290 PMC: 7089966. DOI: 10.1038/s41467-020-15328-3.

Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma.

Liu L, Liu Y, Chen X, Wang M, Zhou Y, Zhou P Oncotarget. 2017; 8(27):43990-44003.

PMID: 28410205 PMC: 5546456. DOI: 10.18632/oncotarget.16702.

The neuropilin-like protein ESDN regulates insulin signaling and sensitivity.

Li X, Jung J, Nie L, Razavian M, Zhang J, Samuel V Am J Physiol Heart Circ Physiol. 2016; 310(9):H1184-93.

PMID: 26921437 PMC: 4867389. DOI: 10.1152/ajpheart.00782.2015.

References

Frank S . Growth hormone signalling and its regulation: preventing too much of a good thing. Growth Horm IGF Res. 2001; 11(4):201-12. DOI: 10.1054/ghir.2001.0237. View

Frank S, Gilliland G, Kraft A, Arnold C . Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology. 1994; 135(5):2228-39. DOI: 10.1210/endo.135.5.7956946. View

Liu J, Kimura A, Baumann C, Saltiel A . APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes. Mol Cell Biol. 2002; 22(11):3599-609. PMC: 133825. DOI: 10.1128/MCB.22.11.3599-3609.2002. View

Nelms K, ONeill T, Li S, Hubbard S, Gustafson T, Paul W . Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. Mamm Genome. 1999; 10(12):1160-7. DOI: 10.1007/s003359901183. View

Hu J, Hubbard S . Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins. J Biol Chem. 2005; 280(19):18943-9. DOI: 10.1074/jbc.M414157200. View

Yi W, Kim S, Jiang J, Park S, Kraft A, Waxman D . Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Mol Endocrinol. 1996; 10(11):1425-43. DOI: 10.1210/mend.10.11.8923468. View

Bjorbaek C, Uotani S, da Silva B, Flier J . Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem. 1998; 272(51):32686-95. DOI: 10.1074/jbc.272.51.32686. View

Lanes R . Metabolic abnormalities in growth hormone deficiency. Pediatr Endocrinol Rev. 2006; 2(2):209-15. View

Ohtsuka S, Takaki S, Iseki M, Miyoshi K, Nakagata N, Kataoka Y . SH2-B is required for both male and female reproduction. Mol Cell Biol. 2002; 22(9):3066-77. PMC: 133757. DOI: 10.1128/MCB.22.9.3066-3077.2002. View

10.

Kotani K, Wilden P, Pillay T . SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase. Biochem J. 1998; 335 ( Pt 1):103-9. PMC: 1219757. DOI: 10.1042/bj3350103. View

11.

Ahn M, Katsanakis K, Bheda F, Pillay T . Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling. J Biol Chem. 2004; 279(20):21526-32. DOI: 10.1074/jbc.M307740200. View

12.

Rui L . Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2. Proc Natl Acad Sci U S A. 1999; 96(13):7172-7. PMC: 22043. DOI: 10.1073/pnas.96.13.7172. View

13.

Ren D, Li M, Duan C, Rui L . Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metab. 2005; 2(2):95-104. DOI: 10.1016/j.cmet.2005.07.004. View

14.

Argetsinger L, Norstedt G, Billestrup N, White M . Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J Biol Chem. 1996; 271(46):29415-21. DOI: 10.1074/jbc.271.46.29415. View

15.

Minami A, Iseki M, Kishi K, Wang M, Ogura M, Furukawa N . Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes. 2003; 52(11):2657-65. DOI: 10.2337/diabetes.52.11.2657. View

16.

BANKS A, Davis S, Bates S, Myers Jr M . Activation of downstream signals by the long form of the leptin receptor. J Biol Chem. 2000; 275(19):14563-72. DOI: 10.1074/jbc.275.19.14563. View

17.

Li M, Ren D, Iseki M, Takaki S, Rui L . Differential role of SH2-B and APS in regulating energy and glucose homeostasis. Endocrinology. 2006; 147(5):2163-70. DOI: 10.1210/en.2005-1313. View

18.

Argetsinger L, Campbell G, Yang X, Witthuhn B, Silvennoinen O, Ihle J . Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell. 1993; 74(2):237-44. DOI: 10.1016/0092-8674(93)90415-m. View

19.

Yousaf N, Deng Y, Kang Y, Riedel H . Four PSM/SH2-B alternative splice variants and their differential roles in mitogenesis. J Biol Chem. 2001; 276(44):40940-8. DOI: 10.1074/jbc.M104191200. View

20.

Hu J, Liu J, Ghirlando R, Saltiel A, Hubbard S . Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor. Mol Cell. 2003; 12(6):1379-89. DOI: 10.1016/s1097-2765(03)00487-8. View